The Board of Directors of Gpi has today approved the Draft Financial Statements and the Consolidated Financial Statements for the financial year ended 31 December 2019, prepared in accordance with IAS/IFRS accounting standards.
REVENUE
EUR 241.0 million, +18.3% (FY 2018: EUR 203.7 million)
Adjusted EBITDA
EUR 32.2 million, 14.4% of adjusted revenues (FY 2018 adj.: EUR 28.6 million)
NET PROFIT
EUR 9.8 million, + 3.1% (FY 2018: EUR 9.5 million)
Ten-year contract worth £6.5 million for the blood transfusion information system
Fausto Manzana appointed Executive Chairman, Andrea Di Santo Chief Executive Officer
The rating is “A3.1”
